🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12554+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12554 recruiting trials

Phase 4RecruitingNCT06403943

Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis

👨‍⚕️ WENJUAN NIE, DR, Beijing Chest Hospital📍 1 site📅 Started May 2023View details ↗
NARecruitingNCT05811013

Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis

🏥 Neuromed IRCCS📍 1 site📅 Started May 2023View details ↗
NARecruitingNCT05662540

PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma

🏥 Ruijin Hospital📍 1 site📅 Started May 2023View details ↗
Phase 1, PHASE2RecruitingNCT05671757

Daratumumab in Primary Antiphospholipid Syndrome

👨‍⚕️ Doruk Erkan, M.D., M.P.H., Hospital for Special Surgery, New York: Division of Rheumatology📍 8 sites📅 Started May 2023View details ↗
RecruitingNCT06833632

Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer

👨‍⚕️ Pietro Bertoglio, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started May 2023View details ↗
RecruitingNCT07215754

Real World Evidence of Anifrolumab in Systemic Lupus Erythematosus: Investigator Initiated, Observational, Multicenter Study Evaluating Effectiveness and Safety of Anifrolumab in Active SLE Patients

🏥 University of Pisa📍 1 site📅 Started May 2023View details ↗
RecruitingNCT06746701

Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.

👨‍⚕️ LeDu Zhou, Ph.D, Xiangya Hospital of Central South University📍 4 sites📅 Started May 2023View details ↗
Phase 2RecruitingNCT05289687

Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL

👨‍⚕️ Shira Dinner, MD, Northwestern University📍 1 site📅 Started May 2023View details ↗
RecruitingNCT06694779

Thrombosis in Diffuse Large B-cell Lymphoma:the PREDIC-TO (PREDICt ThrOmbosis) Study

🏥 Fondazione IRCCS San Gerardo dei Tintori📍 1 site📅 Started May 2023View details ↗
NARecruitingNCT04119908

Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases

👨‍⚕️ Antoine Rauch, MD,PhD, University Hospital, Lille📍 1 site📅 Started May 2023View details ↗
Phase 3RecruitingNCT05473520

Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis

👨‍⚕️ Catherine Ong, MRCP PhD, National University Hospital, Singapore📍 6 sites📅 Started May 2023View details ↗
Phase 1RecruitingNCT06593145

CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms

👨‍⚕️ Emilian Snarski, FamiCordTx S.A.📍 2 sites📅 Started May 2023View details ↗
Phase 4RecruitingNCT03826524

Epinephrine Dose: Optimal Versus Standard Evaluation Trial

👨‍⚕️ Paul Dorian, MD, MSc, Unity Health Toronto📍 8 sites📅 Started May 2023View details ↗
NARecruitingNCT05215587

Scandinavian Trial of Uncomplicated Aortic Dissection Therapy

👨‍⚕️ Jacob W Budtz-Lilly, MD PhD, Aarhus University Hospital📍 28 sites📅 Started May 2023View details ↗
NARecruitingNCT05390853

Active tDCS Versus Sham tDCS for Upper Limb Recovery in Incomplete Tetraplegic Patients

👨‍⚕️ Silvia Olivi, MD, Montecatone Rehabilitation Institute S.p.A.📍 1 site📅 Started May 2023View details ↗
NARecruitingNCT06227780

Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders

👨‍⚕️ Ernest V Pedapati, MD, Children's Hospital Medical Center, Cincinnati📍 1 site📅 Started May 2023View details ↗
Phase 2RecruitingNCT05600686

Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma

👨‍⚕️ Joseph M Tuscano, University of California, Davis📍 2 sites📅 Started May 2023View details ↗
NARecruitingNCT05861245

Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base

🏥 Quironsalud📍 1 site📅 Started May 2023View details ↗
NARecruitingNCT05722340

NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases

🏥 University Hospital, Montpellier📍 1 site📅 Started May 2023View details ↗
Phase 1, PHASE2RecruitingNCT05919264

FOG-001 in Locally Advanced or Metastatic Solid Tumors

👨‍⚕️ Jorge Ramos, DO, Parabilis Medicines, Inc.📍 23 sites📅 Started May 2023View details ↗
← PreviousPage 405 of 628Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →